Paris (France), 05 May 2008
Adenuric® (febuxostat) receives marketing authorisation in the European Union
Adenuric® represents the first major treatment of chronic hyperuricemia in gout for more than forty years.
Adenuric® represents the first major treatment of chronic hyperuricemia in gout for more than forty years.
Paris (France), 29 April 2008
Colloque Médecine et Recherche of La Fondation Ipsen: “Intracellular Traffic and Neurodegenerative Disorders”
The 23rd Colloque Médecine et Recherche of La Fondation Ipsen dedicated to the Alzheimer series was held in Paris on 28 April 2008.
The 23rd Colloque Médecine et Recherche of La Fondation Ipsen dedicated to the Alzheimer series was held in Paris on 28 April 2008.
Paris (France), 29 April 2008
Ipsen’s first quarter 2008 sales
Ipsen (Euronext: IPN) reported today its sales for the first quarter 2008.
Ipsen (Euronext: IPN) reported today its sales for the first quarter 2008.
